Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 6/20 | 0.68 |
| ▸ | MAPT | P10636 | 5/20 | 0.68 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.68 |
| ▸ | MEN1 | O00255 | 3/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.68 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.68 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.68 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.68 |
| ▸ | USP2 | O75604 | 2/20 | 0.68 |
| ▸ | GAA | P10253 | 1/20 | 0.68 |
| ▸ | HPGD | P15428 | 1/20 | 0.68 |
| ▸ | RARB | P10826 | 9/20 | 0.56 |
| ▸ | NPC1 | O15118 | 4/20 | 0.55 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | CASP1 | P29466 | 1/20 | 0.50 |
| ▸ | SLCO1B3 | Q9NPD5 | 1/20 | 0.50 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9636349 | 1.00 | RAB9A (0.68) | RAB9AMAPTSMN1; SMN2MEN1ALDH1A1 | |
| SCHEMBL10469637 | 1.00 | RAB9A (0.68) | RAB9AMAPTSMN1; SMN2MEN1ALDH1A1 | |
| SCHEMBL9636077 | 1.00 | RAB9A (0.68) | RAB9AMAPTSMN1; SMN2MEN1ALDH1A1 | |
| SCHEMBL9636329 | 1.00 | RAB9A (0.68) | RAB9AMAPTSMN1; SMN2MEN1ALDH1A1 | |
| SCHEMBL9637589 | 1.00 | RAB9A (0.68) | RAB9AMAPTSMN1; SMN2MEN1ALDH1A1 | |
| SCHEMBL9636046 | 1.00 | RAB9A (0.68) | RAB9AMAPTSMN1; SMN2MEN1ALDH1A1 | |
| SCHEMBL9636365 | 1.00 | RAB9A (0.68) | RAB9AMAPTSMN1; SMN2MEN1ALDH1A1 | |
| SCHEMBL9636358 | 1.00 | RAB9A (0.68) | RAB9AMAPTSMN1; SMN2MEN1ALDH1A1 | |
| SCHEMBL10469584 | 1.00 | RAB9A (0.68) | RAB9AMAPTSMN1; SMN2MEN1ALDH1A1 | |
| SCHEMBL9635847 | 1.00 | RAB9A (0.68) | RAB9AMAPTSMN1; SMN2MEN1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0293764-B1 | SMECTIC LIQUID CRYSTAL COMPOUND | Chisso Corporation (JP) | 1992-07-29 | — | — | EP | claimed |
| EP-0293764-A2 | Smectic liquid crystal compound | Chisso Corporation (JP) | 1988-12-07 | — | — | EP | claimed |
| US-8778223-B2 | Liquid crystals having cyclohexyl core structures and fluorinated tails | LC VISION, LLC (US) | 2014-07-15 | — | — | US | disclosed |
| US-20120326083-A1 | LIQUID CRYSTALS HAVING CYCLOHEXYL CORE STRUCTURES AND FLUORINATED TAILS | LC VISION, LLC | 2012-12-27 | — | — | US | disclosed |
| EP-0293763-B1 | SMECTIC LIQUID CRYSTAL MIXTURE | CHISSO CORPORATION (JP) | 1992-07-29 | — | — | EP | disclosed |
| EP-0293764-B1 | SMECTIC LIQUID CRYSTAL COMPOUND | Chisso Corporation (JP) | 1992-07-29 | — | — | EP | disclosed |
| US-4882083-A | CONTAINING OPTICALLY ACTIVE COMPOUND; HIGH SPEED RESPONSE DISPLAY ELEMENT | CHISSO CORPORATION (JP) | 1989-11-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120326083-A1 | LIQUID CRYSTALS HAVING CYCLOHEXYL CORE STRUCTURES AND FLUORINATED TAILS | Q6ZSR9, CRACR2A, RCC1 | RAB9A 2644/4885MAPT 295/4885SMN1; SMN2 3431/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.